AWA
ABBV icon

Artemis Wealth Advisors’s AbbVie ABBV Stock Holding History

Artemis Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-335
Closed -$36.1K – 75
2021
Q3 		$36.1K Buy
+335
New +$38.3K 0.01% 57
2017
Q2 		– Sell
-69
Closed -$4.5K – 25
2017
Q1 		$4.5K Hold
69
– – ﹤0.01% 37
2016
Q4 		$4K Buy
+69
New +$4.21K ﹤0.01% 29

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artemis Wealth Advisors's ABBV Position: Q4 2021 in Review

Artemis Wealth Advisors sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 335 shares — an estimated $36.1K sold.

Artemis Wealth Advisors first reported a position in ABBV in Q4 2016 and held it in 3 quarters. The position peaked at $36.1K in Q3 2021. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

  • Artemis Wealth Advisors reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
  • Artemis Wealth Advisors sold 335 AbbVie shares in Q4 2021, an estimated $36.1K.
  • Artemis Wealth Advisors first reported a position in AbbVie in Q4 2016 and held it in 3 quarters.
  • Artemis Wealth Advisors's AbbVie position peaked at $36.1K in Q3 2021.
  • 2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Artemis Wealth Advisors's 13F filing for Q4 2021, filed 17 Feb 2023.